Generation of stable PDX derived cell lines using conditional reprogramming-Reference-Cited by-同舟云学术

Generation of stable PDX derived cell lines using conditional reprogramming

Published:2017-12 Issue:1 Volume:16 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Borodovsky Alexandra,McQuiston Travis J.,Stetson Daniel,Ahmed Ambar,Whitston David,Zhang Jingwen,Grondine Michael,Lawson Deborah,Challberg Sharon S.,Zinda Michael,Pollok Brian A.,Dougherty Brian A.,D’Cruz Celina M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-017-0745-1.pdf

Reference10 articles.

1. Siolas D, Hannon GJ. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res. 2013;73(17):5315–9.

2. Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol. 2012;180(2):599–607.

3. Suprynowicz FA, Upadhyay G, Krawczyk E, Kramer SC, Hebert JD, Liu X, Yuan H, Cheluvaraju C, Clapp PW, Boucher RC Jr, et al. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc Natl Acad Sci U S A. 2012;109(49):20035–40.

4. Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, et al. NOTCH1 and SOX10 are essential for proliferation and radiation resistance of cancer stem-like cells in adenoid cystic carcinoma. Clin Cancer Res. 2016;22(8):2083–95.

5. Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med. 2012;367(13):1220–7.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives;Bioactive Materials;2024-02

2. Systems approach for congruence and selection of cancer models towards precision medicine;PLOS Computational Biology;2024-01-10

3. 3D Tumor Models in Urology;International Journal of Molecular Sciences;2023-03-25

4. Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic;Cells;2022-11-30

5. Humanized Mouse Models for Cancer Immunotherapy: A Focus on HumanPBMCandHSPCReconstitution;Animal Models for the Development of Cancer Immunotherapy;2022-08-19